TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in SF-12 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Patients Successfully Undergoing Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incontinence ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin variant quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Quality event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Morphine Equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear of Covid-19
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of subjects with treatment-emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Participants with grade 3 or 4 treatment-emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: suitability of adsorptive patch for collecting VOCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: suitability of Solid Phase Microextraction (SPME) for analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frontal lobe activation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Eastern Cooperative Oncology Group (ECOG) performance status (PS) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change of the non-invasive tear break-up time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of the lipid layer of tear film
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of eligible patients who enroll
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time taken for Programming of artificial intelligence algorithms
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of messages programmed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of daily treatment with oral zinc
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of daily administered zinc as assessed by side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of daily administered zinc as assessed by regular blood tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Intensity of abnormal movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative total tramadol consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Treatment termination due to abnormal laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment termination due to infusion reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of infusion reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of abnormal laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: 30-Day All-Cause Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: CSF Bacterial Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gross Motor Function Measure -66 (GMFM- 66)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant BMI z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal fasting non-HDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Early detection of severe neonatal jaundice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to therapy in DKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical complications of DKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Headache Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameter values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attrition rate over time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recruitment rate over time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Assessment completion at multiple time points
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visit completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Treatment acceptability questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in nail strength and growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in perceived skin health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy in pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of MRI-PDFF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LDL-C in Serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-prandial plasma concentration acyl ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Post-prandial plasma concentration LEAP2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: All-cause hospitalization within 30 days post discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in St. George's Respiratory Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mortality during the hospital stay and after discharge
Endpoint domain: Mortality/survival
Primary endpoint: Change in therapeutic intensity of ICP reducing measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Profile Of Mood States (POMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trail Making Test (TMT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: KOOS test total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in leaflet mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in shoulder range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality of acute pancreatitis
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of cow's milk allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Knowledge Measurement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to setup and prime the machine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence of junctional rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total hemoglobin mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cycling exercise performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Dsg3 autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of Life- Diabetic Neuropathy Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: BERG BALANCE SCALE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Contamination
Endpoint domain: Adverse events/effects
Primary endpoint: Time to AiO2 from 90 to 40%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nine Hole Peg Test (9DPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hoehn and Yahr Scale (HYS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini Mental Test (MMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duruöz Hand Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area Under the Concentration Time Curve (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of moderate-vigorous intense physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with clinically significant abnormal physical exam and vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with reduced pulmonary function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: EEG Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral/Performance Measures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Model Performance Metrics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Community Mobility and Ambulation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of ease of positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Demonstrable use of microskills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Montreal Cognitive Assessment (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes of resting EEG oscillatory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cough detection (precision and recall)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough characterisation (F1-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheezing detection (F1-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with adequate relief of abdominal and stool symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adherence to asthma medication during pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cobb angle of surgical space and adjacent space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants Enrolled in the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Completed the Entire Program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Who Were Mostly or Very Satisfied With the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric Mean of Neutralizing Antibodies (nAbs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Self-management behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Detection of areas with increased 68Ga-FAPi uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in metabolite concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean metabolic turnover over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Myasthenia Gravis Impairment Index (MGII) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Soreness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Composite outcome hospitalization and death
Endpoint domain: Mortality/survival
Primary endpoint: Fungal positivity rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hospital Anxiety and Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Assessment of urine loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Assessment of pelvic floor muscle contraction and toning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited local and systemic reactogenicity symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric mean titer (GMT) of toxin-neutralizing antibody (TNA) 50% neutralization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 50% reduction in intraoperative neuromonitorization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: full recovery intraoperative neuromonitorization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: User Satisfaction with Exercise Sessions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Urine Samples Collected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perinatal Bereavement Care Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Numeric Rate Scores (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait analyses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical performance of Biosilicate in caries lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average stay duration at ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average consciousness recovery duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of ctHPVDNA response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complicated appendicitis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in cognitive function (self-reported)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cognitive function (objective)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and severity of adverse events of special interest (AESIs) and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of premature discontinuation due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of false positive results of MRI DWI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Sleep Health
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of patients maintaining clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2AR measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of knowledge in osteoporosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healing of digital ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T2DM remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of headache day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short form-36 questionnaire (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of Multiplo Complete Syphilis Antibody Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline level of salivary molecular biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Exhaustion Exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Biochemistry of muscle damage biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Biochemistry of blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transfusion reaction
Endpoint domain: Adverse events/effects
Primary endpoint: reaction times of the ANT-I task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of the ANT-I task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of wounds healed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Disease Free Survival (DFS) rate at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: amount of microvascular insulin-mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: KAP score (knowledge, attitude, and practices)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improve in intake of immune boosting nutrients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: R time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal amplitude (MA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clot index (CI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basal Chest Wall Upper-Lower Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: progression-free survival rate at 6-month
Endpoint domain: Mortality/survival
Primary endpoint: Serum concentrations of 25-hydroxyvitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acoustic Voice Features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month change in areal BMD Z-score at the femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-bearing lunge test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kidney imaging evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Depth of Cervical Epithelial Ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale (mRs)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Visual Analog Scale (VAS) pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h average pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isolation of Moraxella catarrhalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: differences in fecal/intestinal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: differences in fecal microbiome diversity and composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbiome signatures for newly diagnosed IBD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Trunk Endurance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ruminative Thought Style
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: low-frequency fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Acceptability of Intervention Scale (AIM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skeletal muscle density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Evaluation of Uterine Fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunological activity in membranous nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Participant invited to consent and consented via e-signature
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant with at least 70% unblinded CGM data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participant completion of questionnaires and per protocol planned remote visits
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Pathological complete response (pCR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyoid displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to enroll patients who meet the inclusion criteria within the target time frame
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to proposed study timelines and anticipated study costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use